Oded Har-Even
Oded's practice focuses on capital markets. He specializes in counseling public companies on financings and ongoing corporate governance, disclosure and compliance matters. Oded has been involved in numerous public offerings and exchange listings in Wall Street of both private and TASE-listed Israeli companies. He has extensive experience representing New York investment banks in public offerings and private placements. Oded is counsel to several Israeli governmental entities that operate in the U.S. He also guides and assists Israeli start-up companies in their various legal needs while establishing presence in the U.S. Oded has been involved in various public interest activities in Israel and New York. He served as a Captain in the Israeli Defense Forces.
News & Publications
- Sullivan & Worcester Ranked in the 2017 Edition of The Legal 500 United States, S&W Press Release (May 31, 2017)
- IVC-ZAG: Israeli startups raise record $4.8b in 2016, Globes, Quoted (January 10, 2017)
- Two U.S. Law Firms Look to a Big New Year in Israel, Law.com, Quoted (October 7, 2016)
- ZAG-S&W Represents Nano Dimension Ltd in U.S. NASDAQ ADS Public Offering, ZAG-S&W Press Release (September 27, 2016)
- U.S. Extends Commitment to Fund Cooperative Energy Commercialization Program for Partnering Israeli and U.S. Companies, Client Advisory (January 21, 2015)
- Stock News Now: Oded Har-Even on Israeli Companies Going Public in the U.S., Stock News Now (September 29, 2014)
- Israeli Parliament Committee Amends Disclosure Requirements of Top Executives' Compensation Terms, Client Advisory (September 23, 2014)
- The Israeli Dash to the NASDAQ, The Jewish Press, Quoted (May 1, 2014)
- Scale-Up Nation: Chasing Israel’s High Growth Clients, Legal Business, Quoted (April 1, 2014)
- Nasdaq Amends Rules for Independence of Compensation Committee Members, Client Advisory (December 9, 2013)
- The Physician Payment Sunshine Act Is Now a Reality for Physicians, Pharmaceutical Companies and Medical Device Manufacturers, Client Advisory (September 25, 2013)
- Rosetta Genomics -- Worth Only $12M and Raises $25M, Globes (August 10, 2012)
- Will Foreign Private Issuers be Subject to a Stricter Disclosure Regime?, Client Advisory (April 18, 2012)
Seminars & Presentations
- Alternative Public Offerings
Oppenheimer & Co. (March 19, 2019) - Navigating the U.S. Regulatory Environment
Sullivan & Worcester Conference Center, New York, NY (October 31, 2017) - Uplisting to a National Exchange ─ What every company needs to know before, during and after an uplisting
2016 Marcum MicroCap Conference, Grand Hyatt New York, NY (June 1, 2016) - Breakfast with Israel’s Ambassador to the United Nations
Sullivan & Worcester Conference Center, New York (May 3, 2016) - 2015 Marcum Microcap Conference
Grand Hyatt, New York, NY (May 28, 2015) - Israeli Tech: On the Cutting Edge of Innovation
ZAG-S&W Conference Center, Boston (April 28, 2015) - 27th Annual ROTH Conference
The Ritz Carlton, Dana Point, CA (March 8, 2015) - Cybertech Israel
ZAG-S&W, New York, NY (February 3, 2015) - Fostering Economic Growth in Israel
ZAG-S&W, 1633 Broadway, New York, New York (June 27, 2014) - App Engagement
ZAG-S&W, 1633 Broadway, New York, New York (March 27, 2014)